U87-MG orthotopic tumor-bearing mice treated with NGR-modified liposomes containing CA4 (NGR-SSL-CA4) had longer median survival (25 days) than mice treated with CA4-containing liposomes (SSL-CA4; 20.5 days) or CA4 alone (19 days). Here, CA4 is linked to neoplasm.